Skip to content
healthcare.dev

Levetiracetam

NDC 87063-190, Levetiracetam, tablet, from ASCLEMED USA INC..

Product NDC
87063-190
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM250 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
87063-190-1287063019012120 TABLET in 1 BOTTLE (87063-190-12)
87063-190-308706301903030 TABLET in 1 BOTTLE (87063-190-30)
87063-190-608706301906060 TABLET in 1 BOTTLE (87063-190-60)
87063-190-908706301909090 TABLET in 1 BOTTLE (87063-190-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a3c57d82-511c-4c7d-84ff-f791f931f576

Use it

Look up 87063-190 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.